Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
The Director, Government Pricing and Compliance leads a high-performing team responsible for the calculation, analysis, and reporting of all U.S. government pricing programs, ensuring full compliance with federal and state regulations. This role will oversee and manage all proposed policy rules coming from the government regarding lower drug pricing proposals, including but not limited to, the recent CMMI demonstration projects and related Most Favored Nation (MFN) proposals.
Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
Boehringer Ingelheim